T138067 Sodium
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T138067 Sodium, covering 2013-06-25 to 2013-06-25. Get the full timeline:
Most recent: Clinical Trial Update: T138067 Sodium in Treating Patients With Advanced Refractory Cancer [Phase 1]